ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

ASCO Honors Community Practices For Trial Participation.

June 1, 2007

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

March 12, 1999